World ADC Event Series

Roche seems to be the pharmaceutical company on the move in 2025, with its third big ADC deal of the year—this time with Oxford BioTherapeutics! Congratulations to Christian Rohlff and the rest of the team. Exciting stuff! I did fear that in Q1 of 2025, the dealmaking pace might slow down in conjugate-based therapeutics, but these sorts of pharma deals show that the industry's hot topic is still very much a focal point strategically for most. Nowhere is that more evident than in Asia right now. You'll be able to connect with more of your peers than ever at our exciting Korea based World ADC Event Series this June - let me know if you need more information.

ADC Asia is just over a couple of months away. I feel like most of the industry news I see relating to ADCs currently has a link to an APAC company involved in it. Wanted to spotlight some of our fantastic partners ahead of our return to Korea this June. If you think you should be joining them please do not hesitate to shoot me a message. World ADC Event Series https://ter.li/6hs3gx

Swipe to discover the speaker's latest thoughts on why they are excited for World ADC Asia! Ready to explore groundbreaking data for next-generation ADCs and connect with the ADC community? The 4th World ADC Asia Summit offers the most comprehensive platform, bringing together Asia's cutting-edge innovators with Western expertise to pave the way for ADC success across the region. Connect with over 40+ industry-leading speakers from top companies like AstraZeneca, Daiichi Sankyo, leading Asian ADC biotechs, innovative start-ups, and top-tier ADC service providers from all over the world. View the official program here: https://ter.li/cpqpe5

After an intense few days at #WorldADC, we feel reassured that payload selection, indeed is key to making difference. Scroll down and read our conference takeaways to find out why: ?? Heidelberg Pharma AG highlighted how payload selection plays a critical role in determining the effectiveness of ADCs. ?? Advances in linker design are improving both the efficacy and safety of ADCs. Innovations like STRO-004 from Sutro Biopharma, Inc., PL2202 from ADC Therapeutics, MMAU from Glycos, and AstraZeneca’s conjugation chemistry optimization are shaping the next generation of ADCs. ?? High potential in innovative ADC platforms. Computational advances in accelerating development and addressing specificity are leading the charge. We’re launching the beta version of our ADC Payload Selector soon! Fill out the pre-registration form below to get early access: https://turbine.ai/demo #AntibodyDrugConjugates #OncologyInnovation #Biotech #Turbine

We are deeply honored to share that the World ADC Event Series has recognized Dr. Toshinori Agatsuma’s remarkable contributions to the field by naming the Long-Standing Contribution Recognition after him. This prestigious accolade celebrates his enduring impact and dedication to advancing antibody-drug conjugate (ADC) research and development. We express our deepest gratitude and look forward to the World ADC San Diego meeting in November where the first award in his name will be presented. Dr. Agatsuma’s legacy will continue to inspire and drive innovation in the ADC community for years to come. ?? Read more about this honor and Dr. Agatsuma’s achievements here:?https://lnkd.in/eReC7tGW #WorldADC #DSProud

The 4th World ADC Asia Summit is your exclusive opportunity to connect with leading experts from both the East and West, showcasing innovative ADC technologies, new clinical data, and essential regulatory and CMC insights. With over 400 industry leaders attending, including representatives from Daiichi Sankyo, AstraZeneca, Duality Biologics, Innovent Bio, Orum Therapeutics, Coherent Biopharma, and more, will you be joining them? Register by midnight this Friday to save $675 and take advantage of the opportunity to connect with industry leaders at the forefront of innovation. This is your chance to build valuable partnerships and advance your ADC initiatives. Explore the agenda and see the industry leaders already signed up here: https://ter.li/74piid #ADC #WorldADC

World ADC London 2025 Award: BEST Poster Submission ???????? Honored to have our posters recognized by World ADC London 2025 attendees as the best submission for driving innovation and delivering impact in the ADC industry. The posters can be found on our website (www.abtis.co.kr) or by contacting our Business Development team - Manki Kim, So Young Yoon, and BonJoon Goo For any questions, inquiries, or an in-depth discussion, please feel free to reach out to us directly and learn more about our exciting work. We look forward to connecting with you! #WorldADC #ADC #ADCTechnology #Siteselectiveconjugation #Innovation #AbTis #AwardWinner

The World ADC LONDON World ADC Event Series this week served as a remarkable gathering, triumphantly bringing together the leading experts in the bioconjugates industry. Our team had an incredibly productive experience here, we would like to extend our sincere appreciation to each of you who attended the presentation, "Expediting Development of Novel ADCs through WuXi XDC’s Innovative Technology Platform and Fully Integrated CMC Services," expertly delivered by Dr. Marie Zhu, our company's CTO. Moreover, we’re also thankful to each of you who dropped by our booth and posters. It was a perfect platform for connecting with industry pioneers and sharing our?forward - looking views on the bioconjugation field. We look forward to continuing our connection with you. You can reach out through: https://lnkd.in/eCgHTVqf

Spoke at World ADC last week. Lots of fun, well done to the Hanson Wade team. Loads of great talks as usual. Big shout out to the photographer for somehow making me look vaguely competent.